Clinical Trial Update: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cotrimoxazole for idiopathic pulmonary fibrosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Cotrimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: TERMINATED